Bausch & Lomb (BLCO) Cash & Equivalents (2021 - 2026)

Bausch & Lomb (BLCO) has 6 years of Cash & Equivalents data on file, last reported at $367.0 million in Q2 2026.

• Quarterly Cash & Equivalents rose 37.97% year-over-year to $367.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $367.0 million (up 37.97% YoY) and the FY2025 annual result came in at $383.0 million, up 25.57% from the prior year.
• Cash & Equivalents climbed to $367.0 million in Q2 2026, from $268.0 million in the prior quarter.
• In the past five years, Cash & Equivalents ranged from a high of $437.0 million in Q2 2022 to a low of $190.0 million in Q1 2022.
• A 5-year average of $317.4 million and a median of $322.0 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2022 — Cash & Equivalents soared 103.45% — and 2025, when it tumbled 35.87%.
• Tracing BLCO's Cash & Equivalents over 5 years: stood at $354.0 million in 2022, then slipped by 6.5% to $331.0 million in 2023, then declined by 7.85% to $305.0 million in 2024, then increased by 25.57% to $383.0 million in 2025, then fell by 4.18% to $367.0 million in 2026.
• The last three Cash & Equivalents figures came in at $367.0 million (Q2 2026), $268.0 million (Q1 2026), and $383.0 million (Q4 2025), per Business Quant data.